Skip to content
Screener

AptarGroup ATR Common Stock Par Value Per Share

Common Stock Par Value Per Share at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$0.250.0%
Trimas logo
TrimasTRS
$0.010.0%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$0.000.0%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$0.000.0%
KORU Medical Systems logo
KORU Medical SystemsKRMD
$0.010.0%
Amcor logo
AmcorAMCR

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$8.63B-5.4%
Enterprise value$9.84B-2.8%
P/E22.3×-1.0×
P/S2.2×-0.3×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000896622-26-000092
In thousands, except share and per share amountsMarch 31, 2026December 31, 2025
Redeemable Noncontrolling Interests26,69426,244
Total Mezzanine Equity26,69426,244
AptarGroup, Inc. stockholders’ equity:
Common stock, $.01 par value, 199.0 million shares authorized, 73.1 million and 72.8 million shares issued as of March 31, 2026 and December 31, 2025, respectively731728
Capital in excess of par value1,192,7051,165,518
Retained earnings2,684,3822,642,552
Accumulated other comprehensive loss(198,716)(186,382)
Less: Treasury stock at cost, 9.2 million and 8.6 million shares as of March 31, 2026 and December 31, 2025(1,049,607)(954,320)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's common stock par value per share?
AptarGroup (ATR) reported common stock par value per share of $0.01 in Q1 2026.
How has AptarGroup's common stock par value per share changed year-over-year?
AptarGroup's common stock par value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
What is the long-term trend for AptarGroup's common stock par value per share?
Over 5 years (2020 to 2025), AptarGroup's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
What does common stock par value per share mean?
The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.

Ask your AI about AptarGroup's common stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude